<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="90890">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02135653</url>
  </required_header>
  <id_info>
    <org_study_id>UPCC 05813</org_study_id>
    <nct_id>NCT02135653</nct_id>
  </id_info>
  <brief_title>A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abramson Cancer Center of the University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abramson Cancer Center of the University of Pennsylvania</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will ascertain the feasibility and effect of Eischens yoga interventions on
      radiationrelated fatigue, sexual dysfunction and urinary incontinence in stage I /II
      prostate cancer patients undergoing radiotherapy with photons and/or protons without
      prostatectomy. Subjects must be smoke free and have not taken regular yoga classes 6 months
      prior to enrollment. Subjects will participate in twice weekly yoga sessions for 8 weeks and
      complete 4 quality of life forms 5 times during study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Number of Adverse Events</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Prostate Cancer Patients</condition>
  <arm_group>
    <arm_group_label>Feasibility</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase II</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiotherapy</intervention_name>
    <arm_group_label>Feasibility</arm_group_label>
    <arm_group_label>Phase II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Eischens Yoga</intervention_name>
    <arm_group_label>Feasibility</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with stage I or II prostate cancer undergoing radiation therapy. Enrolled subjects
        will not have smoked nor taken any regular yoga classes in the 6 months preceding their
        participation in the study.

        Additionally they will have not undergone a surgical prostatectomy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stage I and II prostate cancer patients undergoing active radiation therapy (external
             beam radiation with photon and/ or proton).

          -  Patients of age 18 years, and all races will be included in the study.

          -  All patients must sign an informed consent form approved for this purpose by the
             Institutional Review Board (IRB) of the University of Pennsylvania. 4. Patients must
             be English-speaking.

        Exclusion Criteria:

          -  Patients with medical restrictions that may interfere with or prevent them from
             taking part in the yoga interventions per their physician orders.

          -  Active smokers, as smoking may interfere with relaxation and breathing modalities of
             the yoga interventions. (Smokers that have been smoke free for 6 months may be
             included)

          -  Patients who currently practice or have recently practiced yoga (taken a yoga class
             on a regular basis in the last 6 months).

          -  Patients who underwent surgical prostatectomy.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neha Vapiwala, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Abramson Cancer Center of the University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neha Vapiwala, MD</last_name>
    <phone>855-216-0098</phone>
    <email>PennCancerTrials@emergingmed.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Abramson Cancer Center of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neha Vapiwala, MD</last_name>
      <phone>855-216-0098</phone>
      <email>PennCancerTrials@emergingmed.com</email>
    </contact>
    <investigator>
      <last_name>Neha Vapiwala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 8, 2014</lastchanged_date>
  <firstreceived_date>May 2, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
